Optofluidics
Philadelphia, US
Founders & leadership
RW
Robert WickeExecutive Officer, Director
RH
Robert HartExecutive Officer
BC
Bernardo CordovezExecutive Officer
Reported raises · per SEC filings
Form D private placements$7MraisedDec 2022 · 11 investors · Biotechnology
Rule 506(b)$6.7MraisedApr 2020 · 14 investors · Biotechnology
Rule 506(b)$5.6MraisedDec 2018 · 6 investors · Other Technology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.